Sarepta Therapeutics, Inc. (SRPT) Debt-to-equity % [USD] 2013 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sarepta Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2013 to 2024.
  • Sarepta Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 283 %, a 36.8% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 283 -165 -36.8% Mar 31, 2024
Q4 2023 308 -106 -25.6% Dec 31, 2023
Q3 2023 377 +57.2 +17.9% Sep 30, 2023
Q2 2023 449 +151 +50.8% Jun 30, 2023
Q1 2023 447 +123 +37.9% Mar 31, 2023
Q4 2022 414 +45.5 +12.3% Dec 31, 2022
Q3 2022 320 -76.1 -19.2% Sep 30, 2022
Q2 2022 298 -24.2 -7.5% Jun 30, 2022
Q1 2022 324 +71.2 +28.1% Mar 31, 2022
Q4 2021 369 +167 +82.7% Dec 31, 2021
Q3 2021 396 +228 +136% Sep 30, 2021
Q2 2021 322 +188 +141% Jun 30, 2021
Q1 2021 253 +151 +147% Mar 31, 2021
Q4 2020 202 +132 +189% Dec 31, 2020
Q3 2020 168 +110 +191% Sep 30, 2020
Q2 2020 134 +75.2 +128% Jun 30, 2020
Q1 2020 103 +40.3 +64.8% Mar 31, 2020
Q4 2019 69.8 -0.83 -1.18% Dec 31, 2019
Q3 2019 57.7 -15.8 -21.5% Sep 30, 2019
Q2 2019 58.7 +1.49 +2.61% Jun 30, 2019
Q1 2019 62.3 +16.2 +35% Mar 31, 2019
Q4 2018 70.7 +36.8 +109% Dec 31, 2018
Q3 2018 73.4 +54.7 +292% Sep 30, 2018
Q2 2018 57.2 +36.5 +177% Jun 30, 2018
Q1 2018 46.1 +20.6 +80.5% Mar 31, 2018
Q4 2017 33.9 +1.74 +5.42% Dec 31, 2017
Q3 2017 18.8 -18.4 -49.5% Sep 30, 2017
Q2 2017 20.7 -31.9 -60.7% Jun 30, 2017
Q1 2017 25.6 -20.7 -44.7% Mar 31, 2017
Q4 2016 32.1 -5.13 -13.8% Dec 31, 2016
Q3 2016 37.1 +7.67 +26% Sep 30, 2016
Q2 2016 52.6 +31.7 +151% Jun 30, 2016
Q1 2016 46.2 +30.8 +200% Mar 31, 2016
Q4 2015 37.3 +21.8 +141% Dec 31, 2015
Q3 2015 29.5 +14.3 +94.4% Sep 30, 2015
Q2 2015 21 +2.8 +15.4% Jun 30, 2015
Q1 2015 15.4 -14.5 -48.5% Mar 31, 2015
Q4 2014 15.4 -29.7 -65.8% Dec 31, 2014
Q3 2014 15.2 -47 -75.6% Sep 30, 2014
Q2 2014 18.2 Jun 30, 2014
Q1 2014 29.9 Mar 31, 2014
Q4 2013 45.2 Dec 31, 2013
Q3 2013 62.1 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.